← Evidence map

ReviewGene therapy2022

Genome editing using CRISPR/Cas9 to treat hereditary hematological disorders.

Yan Chen et al.PubMed ↗Publisher ↗

No numbers read from the abstract.

15 papers cite it

2021
2022
2023
2024
2025
2026
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 33750926